Skip to search formSkip to main contentSkip to account menu

mosapride

Known as: 4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide, Benzamide, 4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) 
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (2)

AS 4370mosapride citrate

Broader (4)

BenzamidesGastrointestinal AgentsMorpholinesSerotonin Agonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Mosapride treatment for functional dyspepsia: A meta‐analysis
The aim of this study was to assess the therapeutic effect of mosapride in patients with functional dyspepsia (FD). 
2014
2014
Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers
BackgroundThe effects of the prokinetic drug mosapride on esophageal motor activity vary at standard doses. In addition to… 
2013
2013
Effect of DA‐9701, a novel prokinetic agent, on stress‐induced delayed gastric emptying and hormonal changes in rats
Background  DA‐9701 is a novel prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. This study aimed to evaluate… 
2012
2012
Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors.
2007
2007
The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
The blocking effect of three 5-HT(4) agonists, cisapride, mosapride, and the newly discovered CJ-033466 on the human ether-a-go… 
2005
2005
Validation and application of a high-performance liquid chromatography--tandem mass spectrometry assay for mosapride in human plasma.
A simple, rapid, sensitive and specific liquid chromatography-tandem mass spectrometry method was developed and validated for… 
2005
2005
Effects of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on electrical activity of the small intestine and cecum in horses.
OBJECTIVE To examine the effects of various doses of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on motility of the… 
2003
2003
5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract.
2002
2002
5-HT4 receptor enhances the propulsive power of the peristaltic reflex in the rat distal colon
2002
2002
Teratogenicity of the I(Kr)-blocker cisapride: relation to embryonic cardiac arrhythmia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)